4/3
06:01 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was given a new $105.00 price target on by analysts at UBS Group AG.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was given a new $105.00 price target on by analysts at UBS Group AG.
3/31
08:16 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at HC Wainwright from $70.00 to $100.00. They now have a "buy" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at HC Wainwright from $70.00 to $100.00. They now have a "buy" rating on the stock.
3/28
10:57 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Stifel Nicolaus from $74.00 to $108.00. They now have a "buy" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Stifel Nicolaus from $74.00 to $108.00. They now have a "buy" rating on the stock.
3/28
08:49 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/28
04:42 am
slno
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? [Yahoo! Finance]
Low
Report
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? [Yahoo! Finance]
3/27
02:12 pm
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
3/27
10:20 am
slno
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, Pulling Aardvark Higher [Yahoo! Finance]
Low
Report
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, Pulling Aardvark Higher [Yahoo! Finance]
3/27
09:23 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Cantor Fitzgerald from $67.00 to $123.00. They now have an "overweight" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Cantor Fitzgerald from $67.00 to $123.00. They now have an "overweight" rating on the stock.
3/27
09:23 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Robert W. Baird from $72.00 to $102.00. They now have an "outperform" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Robert W. Baird from $72.00 to $102.00. They now have an "outperform" rating on the stock.
3/26
08:13 pm
slno
Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome [Yahoo! Finance]
3/26
05:15 pm
slno
Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome
High
Report
Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome
3/5
10:11 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
3/3
08:10 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
2/27
05:49 pm
slno
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
2/27
04:05 pm
slno
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Medium
Report
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
2/14
08:07 pm
slno
Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drug [Yahoo! Finance]
Low
Report
Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drug [Yahoo! Finance]
2/13
04:09 am
slno
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work [Yahoo! Finance]
Medium
Report
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work [Yahoo! Finance]
2/5
06:28 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
1/29
06:57 pm
slno
Soleno Therapeutics to Participate in Upcoming February Investor Conferences [Yahoo! Finance]
Medium
Report
Soleno Therapeutics to Participate in Upcoming February Investor Conferences [Yahoo! Finance]
1/29
04:05 pm
slno
Soleno Therapeutics to Participate in Upcoming February Investor Conferences
Low
Report
Soleno Therapeutics to Participate in Upcoming February Investor Conferences